Labaton Secures $23.8M In Fees For Amgen Securities Deal
By Suevon Lee ( October 26, 2016, 10:38 PM EDT) -- A California federal judge on Wednesday granted $23.8 million in attorneys' fees to Labaton Sucharow LLP and others serving as class counsel to investors who reached a $95 million settlement with Amgen Inc. over the company's alleged misstatements about two of its anti-anemia drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.